Table 1.
N or Range | % or Median | |
---|---|---|
Gender | ||
Male | 102 | 53% |
Female | 90 | 47% |
Age range (Median) | ||
Male | 28–108 | 68 |
Female | 28–95 | 67 |
Vaccination | ||
Vaccinated (≥ 1 dose) | 190 | 99% |
Unvaccinated or Unknown | 2 | 1% |
Immune status | ||
Immunosuppresseda | 75 | 39% |
Not Immunosuppressed | 117 | 61% |
COVID-related hospitalization | ||
Hospitalized | 122 | 64% |
Not hospitalized | 70 | 36% |
Diabetes mellitus | ||
Yes | 105 | 55% |
No | 87 | 45% |
aImmunosuppression due to active treatment for solid tumor and hematologic malignancies, recipients of solid organ transplant, patients with autoimmune diseases, or HIV infection as included in Supplemental Dataset 1